0001415889-25-005108.txt : 20250221 0001415889-25-005108.hdr.sgml : 20250221 20250221170844 ACCESSION NUMBER: 0001415889-25-005108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250219 FILED AS OF DATE: 20250221 DATE AS OF CHANGE: 20250221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robertson Jenny CENTRAL INDEX KEY: 0001995009 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41855 FILM NUMBER: 25653066 MAIL ADDRESS: STREET 1: C/O LEXEO THERAPEUTICS, INC. STREET 2: 345 PARK AVENUE SOUTH, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc. CENTRAL INDEX KEY: 0001907108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 854012572 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: FLOOR 6 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 547-9879 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: FLOOR 6 CITY: NEW YORK STATE: NY ZIP: 10010 4 1 form4-02212025_100240.xml X0508 4 2025-02-19 0001907108 Lexeo Therapeutics, Inc. LXEO 0001995009 Robertson Jenny C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6 NEW YORK NY 10010 false true false false Chief Legal Officer 0 Common Stock 2025-02-19 4 S 0 2101 4.413 D 57899 D Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs"). Includes 54,062 RSUs. /s/ Youjin Choi, Attorney-in-Fact 2025-02-21